Protective effects of thromboxane A2 synthetase inhibitor (OKY-046) on hepatic ischemia-reperfusion injury in rats with obstructive jaundice

Journal of Hepato-Biliary-Pancreatic Surgery

Volumn 3, Issue 1, 1996, Pages 60-65

  Orita, Masahiko ^a  

^a YAMAGUCHI UNIVERSITY   (Japan)

Author keywords

Interleukin 8; Kupffer cell; Liver ischemia reperfusion injury; Obstructive jaundice; Thromboxane A2 synthetase inhibitor

Indexed keywords

EID: 0009636331     PISSN: 09441166     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01212782     Document Type: Article

References (5)

1. Szczlik A, Gerglewski RJ, Musial L, Grodinska M, Serwonska L, Marcinkiewicz WS (1978) Arachidonic acid-induced platelet aggregation and thromboxane A, generation in patients with coronary heart disease. Acta Biol Med Der 37:741
2. Kuroe K, Kurokawa T, Nishikimi M, Nonami A, Harada A. Nakao A, Takagi H (1991) Effects of thromboxane A2 synthetase inhibitor on postischemic liver injury in rats. Eur Surg Res 23:2026
3. Suehiro T, Yanaga K, Itasaka H, Kishikawa K, Shirabe K, Sugimachi K (1994) Benificial effect of thromboxane A2 synthetase inhibitor on cold-stored rat liver. Transplantation 58:768-773
4. Isozaki H, Okajima K, Hara H, Kobayashi M (1994) The protective effect of thromboxane A2 synthetase inhibitor against ischemic liver injury. Jpn J Surg 24:435-440
5. 2 and thromboxane antagonist on liver ischemic injury. Eur Surg Res 21:213-217